Pharmalittle: We’re reading about a Sarepta setback with a DMD drug, FDA workload causes a delay, and more Nonprofit led by 23andMe co-founder Anne Wojcicki won a last-minute bidding war to buy most company assets for $305M

https://www.statnews.com/pharmalot/2025/06/16/lilly-weight-obesity-23andme-sanders-advertising-abbvie-cdc-vaccines-rfk-wojcicki-fda-kalvista-sarepta-dmd-gene/